Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 7.450\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) O=C(NCCCN1CCOCC1)c1ccc(S(=O)(=O)Nc2cccc(C(F)(F)F)c2)cc1
b.) Cc1ccc(C(C)(O)CS(=O)(=O)Cc2ccccc2Cl)cc1
c.) CCCCCN(C(=O)CN1CCC(Cc2ccccc2)CC1)c1c(N)n(CCCC)c(=O)[nH]c1=O
d.) Cc1cc(NC(=O)CN2C(=O)c3ccccc3C2=O)no1
e.) CC1(C)Cc2c(sc3nc[nH]c(=O)c23)CO1
Answer: c. CCCCCN(C(=O)CN1CCC(Cc2ccccc2)CC1)c1c(N)n(CCCC)c(=O)[nH]c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCCN(C(=O)CN1CCC(Cc2ccccc2)CC1)c1c(N)n(CCCC)c(=O)[nH]c1=O
CCCCCN(C(=O)CN1CCC(Cc2ccccc2)CC1)c1c(N)n(CCCC)c(=O)[nH]c1=O
N-(6-amino-1-butyl-2,4-dioxopyrimidin-5-yl)-2-(4-benzylpiperidin-1-yl)-N-pentylacetamide